Parse Biosciences, which commercialized the single-cell RNA seq method known as SPLiT-seq, is hoping to make scRNA-seq easier and more accessible.

Parse Biosciences today announced a $7 million investment round to support growth of its single cell sequencing technology. The biotech startup sells a “Whole Transcriptome Kit” that can ...

Earlier this year, Parse Biosciences introduced split-pool combinatorial barcoding to the market – a disruptive, intrinsically scalable single-cell RNA-seq technology that doesn’t require a ...

Parse Biosciences CTO Charles Roco and CEO Alex Rosenberg. (Parse Photo) ... The cells from different pools are then combined, split into new pools and another tag added.

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, ... Launched in 2021, Evercode split-pool combinatorial barcoding is a simple, ...

Split Biosciences, now Parse Biosciences, Announces $7M in Series A Funding to Democratize Single Cell RNA Sequencing. As adoption of scRNA-seq in industry and academia accelerates, Parse Biosciences ...

Vanderbilt University Medical Center and Parse Biosciences, an innovator in single-cell sequencing, are collaborating on a ...

Split Biosciences, now Parse Biosciences, Announces $7M in Series A Funding to Democratize Single Cell RNA Sequencing. Tuesday, January 26, 2021 Genetics & Stem Cells News. Advertisement ...

SEATTLE — Parse Biosciences today announced a partnership with Decode Science to provide Parse’s single-cell RNA-seq solution to the Australian and New Zealand markets. Under an agreement between the ...

Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Boosting Usability and Performance. Thursday, February 22, 2024 10:12AM IST (4:42AM GMT) ...